Reversal of sibutramine-induced anorexia with a selective 5-HT2C receptor antagonist

Psychopharmacology

Volumn 214, Issue 4, 2011, Pages 941-947

  Higgs, Suzanne ^b   Cooper, Alison J ^a   Barnes, Nicholas M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NONE

Author keywords

Bout structure; Licking behaviour; Satiety; Serotonin

Indexed keywords

6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; GLUCOSE; SIBUTRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SELECTIVITY; GLUCOSE INTAKE; LICKING; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; SATIETY;

AMINOPYRIDINES; ANIMALS; ANOREXIA; APPETITE DEPRESSANTS; BEHAVIOR, ANIMAL; CYCLOBUTANES; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLES; MALE; RATS; RATS, INBRED STRAINS; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS;

EID: 79953655554     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2106-2     Document Type: Article

References (37)

1. Asin KE, Davis JD, Bednarz L (1992) Differential effects of serotonergic and catecholaminergic drugs on ingestive behavior. Psychopharmacology 109:415-421
2. Astrup A (2010) Drug management of obesity - efficacy versus safety. N Engl J Med 363:288-290
3. Bray GA, Ryan DH, Gordon D et al (1996) A double-blind randomised placebo-controlled trial of sibutramine. Obes Res 4:263-270 (Pubitemid 126690229)
4. Breslin PAS, Davis JD, Rosenak R (1996) Saccharin increases the effectiveness of glucose in stimulating ingestion in rats but has little effect on negative feedback. Physiol Behav 60:411-416 (Pubitemid 26274279)
5. Clifton PG, Lee MD, Dourish CT (2000) Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist, and d-fenfluramine on feeding patterns in the rat. Psychopharmacology 152:256-267
6. Cooper SJ, Higgs, S (2005) Benzodiazepine effects on licking responses for sodium chloride solutions in water-deprived male rats. Physiol Behav 85:252-258 (Pubitemid 40840740)
7. Davis JD, Smith GP (1992) Analysis of the microstructure of the rhythmic tongue movements of rats ingesting maltose and sucrose solutions. Behav Neurosci 106:217-228
8. Davis JD, Smith GP, Singh B, McCann DL (2001) The impact of sucrose-derived unconditioned and conditioned negative feedback on the microstructure of ingestive behavior. Physiol Behav 72:393-402 (Pubitemid 32234426)
9. Dutton AC, Barnes NM (2006) Anti-obesity pharmacotherapy: future perspectives utilising 5-HT2C receptor agonists. Drug Discov Today Ther Strat 3:577-583 (Pubitemid 46098477)
10. Golozoubova V, Strauss F, Malmlöf K (2006) Locomotion is the major determinant of sibutramine-induced increase in energy expenditure. Pharmacol Biochem Behav 83:517-527 (Pubitemid 43817121)
11. Grignaschi G, Fanelli E, Scagnol I, Samanin R (1999) Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats. Br J Pharmacol 127:1190-1194 (Pubitemid 29326642)
12. Halford JCG, Heal DJ, Blundell JE (1995) Effects in the rat of sibutramine on food-intake and the behavioral satiety sequence. Br J Pharmacol 114:387-387
13. Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC (1998) Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int J Obes Relat Metab Disord 22(Suppl 1):S18-S28 (Pubitemid 128705406)
14. Hewitt KN, Lee MD, Dourish CT, Clifton PG (2002) Serotonin 2C receptor agonists and the behavioural satiety sequence in mice. Pharmacol Biochem Behav 71:691-700 (Pubitemid 34219219)
15. Higgs S, Cooper SJ (1996) Effects of the benzodiazepine receptor inverse agonist. Ro 15-4513 on the ingestion of sucrose and sodium saccharin solutions: a microstructural analysis of licking behavior. Behav Neurosci 110:559-566
16. Higgs S, Cooper SJ (1997) Midazolam induced rapid changes in licking behaviour: evidence for involvement of endogenous opioid peptides. Psychopharmacology 131:278-286 (Pubitemid 27283590)
17. Higgs S, Cooper SJ (1998) Effects of benzodiazepine receptor ligands on the ingestion of sucrose, intralipid, and maltodextrin: an investigation using a microstructural analysis of licking behavior in a brief contact test. Behav Neurosci 112:447-457 (Pubitemid 28196867)
18. Higgs S, Cooper SJ (2000) The effect of the dopamine D2 antagonist raclopride on the pattern of licking microstructure induced by midazolam in the rat. Eur J Pharmacol 409:73-80
19. Jackson HC, Bearham MC, Hutchins LJ et al (1997a) Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br J Pharmacol 121:1613-1618 (Pubitemid 27343387)
20. Jackson HC, Needham AM, Hutchins LJ, Mazurkiewicz SE, Heal DJ (1997b) Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br J Pharmacol 121:1758-1762 (Pubitemid 27343407)
21. Kennett GA, Wood MD, Glen A, Grewal S, Forbes I, Gadre A, Blackburn TP (1994) In vivo properties of SB 200646A, a 5- HT2C/2B receptor antagonist. Br J Pharmacol 111:797-802
22. 2C receptor antagonist. Neuropharmacology 36:609-620
23. Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M (2004) Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. Naunyn Schmiedebergs Arch Pharmacol 370:114-123 (Pubitemid 39222863)
24. Lee, MD, Simansky, KJ (1997) CP-94,253: A selective serotonin(1B) (5-HT1B) agonist that promotes satiety. Psychopharmacology 131:264-270 (Pubitemid 27283588)
25. Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM (1985) Receptor-binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27:600-611 (Pubitemid 15010691)
26. Li ZP, Maglione M, Tu WL, Mojica W, Arterburn D, Shugarman LR, Hilton L, Suttorp M, Solomon V, Shekelle PG, Morton SC (2005) Meta-analysis: Pharmacologic treatment of obesity. Ann Intern Med 142:532-546
27. Luque CA, Rey JA (1999) Sibutramine: A serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity. Ann Pharmacother 33:968-978 (Pubitemid 29420996)
28. McNeely W, Goa KL (1998) Sibutramine - A review of its contribution to the management of obesity. Drugs 56:1093-1124 (Pubitemid 29010230)
29. Monsma FJ Jr, Shen Y, Ward RP, Hamblin MW, Sibley DR (1993) Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 43:320-327 (Pubitemid 23081986)
30. 2C receptors in CHO-K1 cells. Br J Pharmacol 128:13-20
31. 7 serotonin receptor subtype. J Biol Chem 268:18200-18204
32. Smith BM, Smith JM, Tsai JH, Schultz JA, Gilson CA, Estrada SA, Chen RR, Park DM, Prieto EB, Gallardo CS, Sengupta D, Dosa PI, Covel JA, Ren A, Webb RR, Beeley NR, Martin M, Morgan M, Espitia S, Saldana HR, Bjenning C, Whelan KT, Grottick AJ, Menzaghi F, Thomsen WJ (2008) Discovery and structureactivity relationship of (1R)-8-chloro-2, 3, 4, 5-tetrahydro-1- methyl-1 H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity. J Med Chem 51:305-313
33. Smith SR, Prosser WA, Donahue DJ, Morgan ME, Anderson CM, Shanahan WR (2009) Lorcaserin (APD356), a selective 5-HT (2C) agonist, reduces body weight in obese men and women. Obesity 17:494-503
34. Spector AC, Klumpp PA, Kaplan JM (1998) Analytical issues in the evaluation of food deprivation and sucrose concentration effects on the microstructure of licking behavior in the rat. Behav Neurosci 112:678-694 (Pubitemid 28309158)
35. Tallett AJ, Blundell JE, Rodgers RJ (2009) Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats. Behav Brain Res 198:359-365
36. Thomsen WJ, Grottick AJ, Menzaghi F, Reyes-Saldana H, Espitia S, Yuskin D, Whelan K, Martin M, Morgan M, Chen W, Al- Shamma H, Smith B, Chalmers D, Behan D (2008) Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther 325:577-587 (Pubitemid 351574813)
37. Vickers SP, Clifton PG, Dourish CT, Tecott LH (1999) Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice. Psychopharmacology 143:309-314 (Pubitemid 29204986)